Pharma Mar (PHMMF) Stock Forecast & Price Target

$45.85

0.00 (0.00%)

(As of 09/13/2024 ET)

Stock Analysis Analyst Forecasts Chart Headlines Short Interest

Pharma Mar - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Strong Buy
Based on 1 Analyst Ratings

Based on 1 Wall Street analysts who have issued ratings for Pharma Mar in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 1 analysts, 1 has given a strong buy rating for PHMMF.

Consensus Price Target

N/A

According to the 1 analysts' twelve-month price targets for Pharma Mar,

Type	Current Forecast 9/16/23 to 9/15/24	1 Month Ago 8/17/23 to 8/16/24	3 Months Ago 6/18/23 to 6/17/24	1 Year Ago 9/16/22 to 9/16/23
Consensus Rating	Strong Buy	Strong Buy	N/A	N/A
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	N/A	N/A
Buy	0 Buy rating(s)	0 Buy rating(s)	N/A	N/A
Hold	0 Hold rating(s)	0 Hold rating(s)	N/A	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	N/A	N/A
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A

Get Pharma Mar Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for PHMMF and its competitors with MarketBeat's FREE daily newsletter.

Ad Porter & Company

War on Elon Escalates…

Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

Click here to learn how you can benefit from its widespread distribution.

PHMMF Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

PHMMF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Pharma Mar Stock vs. The Competition

Type	Pharma Mar	Medical Companies	S&P 500
Consensus Rating Score	4.00	2.77	2.50
Consensus Rating	Strong Buy	Moderate Buy	Moderate Buy
Predicted Upside		1,059.97% Upside	8.61% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
8/1/2024	Chardan Capital 2 of 5 stars	K. Nakae Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 03:42 AM ET.

PHMMF Forecast - Frequently Asked Questions

Should I buy or sell Pharma Mar stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Pharma Mar in the last year. There is currently 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" PHMMF shares.
Has Pharma Mar been upgraded by Wall Street analysts recently?: Over the previous 90 days, Pharma Mar's stock had 1 upgrade by analysts.
What analysts cover Pharma Mar?: Pharma Mar has been rated by research analysts at Chardan Capital in the past 90 days.
Do Wall Street analysts like Pharma Mar more than its competitors?: Analysts like Pharma Mar more than other "medical" companies. The consensus rating for Pharma Mar is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how PHMMF compares to other companies.